
Promising New Gene-Editing Therapy Demonstrates Early Success Against Advanced Gastrointestinal Cancers
MINNEAPOLIS/ST. PAUL — In a groundbreaking advance that combines cutting-edge gene-editing technology with immunotherapy, researchers at the University of Minnesota have successfully completed a first-in-human clinical trial aimed at treating advanced …